IL113767A - Neurotensin antagonist peptides process for their preparation and pharmaceutical compositions containing them - Google Patents
Neurotensin antagonist peptides process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL113767A IL113767A IL11376795A IL11376795A IL113767A IL 113767 A IL113767 A IL 113767A IL 11376795 A IL11376795 A IL 11376795A IL 11376795 A IL11376795 A IL 11376795A IL 113767 A IL113767 A IL 113767A
- Authority
- IL
- Israel
- Prior art keywords
- pct
- compound
- radical
- preparation
- date nov
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C27/00—Processes involving the simultaneous production of more than one class of oxygen-containing compounds
- C07C27/20—Processes involving the simultaneous production of more than one class of oxygen-containing compounds by oxo-reaction
- C07C27/22—Processes involving the simultaneous production of more than one class of oxygen-containing compounds by oxo-reaction with the use of catalysts which are specific for this process
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- C07K7/083—Neurotensin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/18—Kallidins; Bradykinins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9406167A FR2720066B1 (fr) | 1994-05-20 | 1994-05-20 | Peptides antagonistes de la neurotensine. |
Publications (2)
Publication Number | Publication Date |
---|---|
IL113767A0 IL113767A0 (en) | 1995-08-31 |
IL113767A true IL113767A (en) | 1999-04-11 |
Family
ID=9463378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11376795A IL113767A (en) | 1994-05-20 | 1995-05-17 | Neurotensin antagonist peptides process for their preparation and pharmaceutical compositions containing them |
Country Status (13)
Country | Link |
---|---|
US (1) | US5840682A (xx) |
EP (1) | EP0759934B1 (xx) |
JP (1) | JPH10500424A (xx) |
AT (1) | ATE178905T1 (xx) |
AU (1) | AU2619595A (xx) |
DE (1) | DE69509084T2 (xx) |
DK (1) | DK0759934T3 (xx) |
ES (1) | ES2132671T3 (xx) |
FR (1) | FR2720066B1 (xx) |
GR (1) | GR3029950T3 (xx) |
IL (1) | IL113767A (xx) |
WO (1) | WO1995032218A1 (xx) |
ZA (1) | ZA954026B (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0968001B1 (en) * | 1997-02-03 | 2003-11-05 | Mallinckrodt Inc. | Method for the detection and localization of malignant human pancreatic tumours |
DE10226921A1 (de) * | 2002-06-17 | 2003-12-24 | Bayer Ag | Antibakterielle Amid-Makrozyklen |
DE10358824A1 (de) * | 2003-12-16 | 2005-07-21 | Bayer Healthcare Ag | Antibakterielle Makrozyklen mit substituiertem Biphenyl |
DE102005014245A1 (de) * | 2005-03-30 | 2006-10-05 | Aicuris Gmbh & Co. Kg | Antibakterielle Amid-Makrozyklen V |
DE102005014247A1 (de) * | 2005-03-30 | 2006-10-05 | Aicuris Gmbh & Co. Kg | Antibakterielle Amid-Makrozyklen VI |
DE102005032781A1 (de) * | 2005-07-14 | 2007-01-18 | Aicuris Gmbh & Co. Kg | Antibakterielle Amid-Markozyklen VII |
EP2374003B1 (en) | 2009-01-07 | 2015-03-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the treatment, the prognostic assessment and the detection of breast cancer |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4439359A (en) * | 1982-07-02 | 1984-03-27 | Merck & Co., Inc. | Cyclic octapeptide analogs of neurotensin |
US5162497A (en) * | 1987-09-24 | 1992-11-10 | The Administrators Of The Tulane Educational Fund | Bradykinin analogs with non-peptide bond |
US5430047A (en) * | 1994-04-07 | 1995-07-04 | Warner-Lambert Company | Neurotensin antagonists |
FR2720065B1 (fr) * | 1994-05-20 | 1996-06-28 | Rhone Poulenc Rorer Sa | Métabolite de fermentation d'actinomycètes A 9738 intermédiaire pour la préparation d'antagonistes de la neurotensine. |
-
1994
- 1994-05-20 FR FR9406167A patent/FR2720066B1/fr not_active Expired - Lifetime
-
1995
- 1995-05-17 IL IL11376795A patent/IL113767A/xx active IP Right Grant
- 1995-05-17 DE DE69509084T patent/DE69509084T2/de not_active Expired - Fee Related
- 1995-05-17 JP JP7530094A patent/JPH10500424A/ja active Pending
- 1995-05-17 DK DK95920949T patent/DK0759934T3/da active
- 1995-05-17 ZA ZA954026A patent/ZA954026B/xx unknown
- 1995-05-17 WO PCT/FR1995/000643 patent/WO1995032218A1/fr active IP Right Grant
- 1995-05-17 AT AT95920949T patent/ATE178905T1/de not_active IP Right Cessation
- 1995-05-17 EP EP95920949A patent/EP0759934B1/fr not_active Expired - Lifetime
- 1995-05-17 US US08/737,695 patent/US5840682A/en not_active Expired - Fee Related
- 1995-05-17 AU AU26195/95A patent/AU2619595A/en not_active Abandoned
- 1995-05-17 ES ES95920949T patent/ES2132671T3/es not_active Expired - Lifetime
-
1999
- 1999-04-15 GR GR980400478T patent/GR3029950T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH10500424A (ja) | 1998-01-13 |
DK0759934T3 (da) | 1999-08-02 |
EP0759934A1 (fr) | 1997-03-05 |
US5840682A (en) | 1998-11-24 |
ES2132671T3 (es) | 1999-08-16 |
FR2720066A1 (fr) | 1995-11-24 |
AU2619595A (en) | 1995-12-18 |
FR2720066B1 (fr) | 1996-06-28 |
GR3029950T3 (en) | 1999-07-30 |
IL113767A0 (en) | 1995-08-31 |
WO1995032218A1 (fr) | 1995-11-30 |
ATE178905T1 (de) | 1999-04-15 |
DE69509084T2 (de) | 1999-08-12 |
EP0759934B1 (fr) | 1999-04-14 |
ZA954026B (en) | 1996-03-06 |
DE69509084D1 (de) | 1999-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW458986B (en) | Novel thrombin inhibitors, and the salts thereof with physiologically tolerated acids and the stereoisomers thereof | |
IL114156A0 (en) | Substituted azaindolylidene compounds process for their preparation pharmaceutical compositions containing them and their uses | |
WO1995030687A1 (de) | Neurokinin (tachykinin)-antagonisten | |
JPS59205350A (ja) | カルボキシアルキルペプチド誘導体 | |
HUP0102900A2 (hu) | Javított szilárd fázisú peptidszintézis és a szintézisben alkalmazható anyagok | |
ES8600769A1 (es) | Procedimiento de preparar compuestos vinblastinicos y similares | |
JP2012512903A5 (xx) | ||
ES8707547A1 (es) | Procedimiento para preparar un oligopeptidil-argininol u-homoargininol o derivado de estos | |
FR2364948A1 (fr) | Systemes adhesifs comprenant un polyamide contenant une bisamino piperazine | |
CZ333492A3 (en) | Dipeptide of l-azetidine-2-carboxylic acids and l-argininaldehyde, process of its preparation and pharmaceutical preparation in which said dipeptide is comprised | |
HUP0102579A2 (hu) | Antiangiogén hatású peptid gyógyszervegyületek, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk | |
IL113767A (en) | Neurotensin antagonist peptides process for their preparation and pharmaceutical compositions containing them | |
WO2002066500A2 (de) | ANTAGONISTEN FÜR Α4β7-INTEGRIN | |
HU185229B (en) | Process for preparing pharmaceutically active peptides and acetates thereof | |
DE68923592T2 (de) | HIV Protease-Hemmer. | |
DE69116772T2 (de) | Peptid oder seine Salze | |
AU2003283160A1 (en) | Shrew paralytic peptide for use in neuromuscular therapy | |
DE3571990D1 (en) | Reduced peptides, inhibitors of gastric secretion, preparation process and pharmaceutical compositions containing them | |
EP0076557A3 (en) | Peptides and pseudopeptides in which the n terminus bears two substituents | |
GR3036978T3 (en) | Anthracycline conjugates, their preparation and their use as antitumor agents. | |
MX9706927A (es) | Antagonistas biciclicos de taquicininas, preparacion de los mismos y su uso en composiciones farmaceuticas. | |
ES8605769A1 (es) | Un procedimiento para la preparacion de un peptido | |
RU2334760C2 (ru) | Иммуносупрессоры | |
GB1587427A (en) | Polypeptide derivatives | |
MX2022002696A (es) | Composiciones de peptoides antivirales. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed |